Antipsychotic medications are the first-line treatment for people with schizophrenia, although they are not effective in 30% of people with the disorder. These drugs can reduce delusions ...

For 35 years, the FDA has placed onerous restrictions on the only drug it has ever approved for treatment-resistant ...

Using the drugs currently prescribed for schizophrenia or bipolar disorder is like undergoing chemotherapy, he said. “There’s ...

Two clinical studies evaluated the safety and effectiveness of Caplyta in adults with schizophrenia. In both studies, people took either Caplyta or a placebo (a pill with no medicine). The average ...

About one in 300 people worldwide are affected by schizophrenia, but for decades treatment options have been both static and limited. If the FDA approves the twice-daily pill on Thursday ...

XT represents a new medication with a different mechanism of action than other currently available drugs for treating schizophrenia. Like traditional antipsychotics, this drug helps decrease positive ...

For around 70 years, the treatment of schizophrenia has relied almost entirely on drugs that block dopamine receptors, so Cobenfy's action on cholinergic receptors offers a brand new way to treat ...

In April, the American Psychiatric Association (APA) released a comprehensive treatment guideline for treating adults who have been diagnosed with schizophrenia. Titled "The Practice Guideline for ...

XT represents a new medication with a different mechanism of action than other currently available drugs for treating schizophrenia. Like traditional antipsychotics, this drug helps decrease ...